These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6413589)

  • 1. Human factor D of the alternative pathway: purification and quantitation by enzyme amplified electroimmunoassay.
    Truedsson L; Sturfelt G
    J Immunol Methods; 1983 Oct; 63(2):207-14. PubMed ID: 6413589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor D concentrations in normal sera: comparison of immunochemical and functional determinations.
    Sturfelt G; Truedsson L
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):383-9. PubMed ID: 6369875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effective method of simultaneous isolation from human serum of highly purified factors B and D of the alternative pathway of complement activation].
    Soliakov LS; Kozlov LV
    Bioorg Khim; 1983 Apr; 9(4):462-9. PubMed ID: 6567468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.
    Johnson DM; Gagnon J; Reid KB
    Biochem J; 1980 Jun; 187(3):863-74. PubMed ID: 6821372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of human factor D of the alternative pathway of complement.
    Reid KB; Johnson DM; Gagnon J; Phohaska R
    Methods Enzymol; 1981; 80 Pt C():134-43. PubMed ID: 6918766
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor D of the alternative pathway of bovine complement: isolation and characterization.
    Menger M; Aston WP
    Vet Immunol Immunopathol; 1984 Oct; 7(3-4):325-36. PubMed ID: 6568787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequence.
    Davis AE; Zalut C; Rosen FS; Alper CA
    Biochemistry; 1979 Nov; 18(23):5082-7. PubMed ID: 497171
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination in the nanogram range of C1q in serum and unconcentrated CSF by electro-immunodiffusion.
    Schuller E; Helary M
    J Immunol Methods; 1983 Jan; 56(2):159-65. PubMed ID: 6600765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of precipitation in counter current electrophoresis. A sensitive method for detection of mink antibodies to Aleutian disease virus.
    Aasted B; Cohn A
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):15-9. PubMed ID: 7080835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of counterimmunoelectrophoresis in rapid detection of cytomegalovirus antibodies.
    Niebojewski RA; Aguilar-Torres FG; Rytel MW
    Am J Clin Pathol; 1977 Sep; 68(3):343-6. PubMed ID: 197846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody which blocks the function of factor D of human complement.
    Pascual M; Catana E; Spertini F; Macon K; Volanakis JE; Schifferli JA
    J Immunol Methods; 1990 Mar; 127(2):263-9. PubMed ID: 2313104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and partial characterization of bovine and equine factor D.
    Blanchard DB; Leid RW
    Mol Immunol; 1984 Oct; 21(10):869-76. PubMed ID: 6568410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay.
    Barnum SR; Niemann MA; Kearney JF; Volanakis JE
    J Immunol Methods; 1984 Mar; 67(2):303-9. PubMed ID: 6561229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation by the alternative pathway is modified in renal failure: the role of factor D.
    Pascual M; Paccaud JP; Macon K; Volanakis JE; Schifferli JA
    Clin Nephrol; 1989 Oct; 32(4):185-93. PubMed ID: 2805459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroimmunoassay-immunoblotting (EIA-IB) for the utilization of monoclonal antibodies in quantitative immunoelectrophoresis: the method and its applications.
    Bhakdi S; Jenne D; Hugo F
    J Immunol Methods; 1985 Jun; 80(1):25-32. PubMed ID: 4008937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a modified immunoelectroosmophoresis method for Uukuniemi and Runde virus serology.
    Traavik T
    Arch Virol; 1977; 54(3):231-40. PubMed ID: 889446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunoassay for circulating immune complexes using solid phased goat Clq.
    Lin TM; Halbert SP; Cort R; Blaschke MJ
    J Immunol Methods; 1983 Oct; 63(2):187-205. PubMed ID: 6194228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of factor D of the alternative complement pathway.
    Lesavre PH; Müller-Eberhard HJ
    J Exp Med; 1978 Dec; 148(6):1498-509. PubMed ID: 82604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies in rabbits immunized with staphylococcal lipoteichoic acid.
    Aasjord P; Grov A
    Acta Pathol Microbiol Scand B; 1980 Feb; 88(1):53-6. PubMed ID: 6768220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of pig Clq and its structural and functional characterization.
    Simecková J; Dlabac V; Stránský J
    Vet Immunol Immunopathol; 1985 Jun; 9(2):115-30. PubMed ID: 3898551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.